AdaptHealth Target of Unusually High Options Trading (NASDAQ:AHCO)

AdaptHealth Corp. (NASDAQ:AHCO) was the target of unusually large options trading activity on Tuesday. Stock investors bought 4,503 put options on the stock. This represents an increase of 53% compared to the typical volume of 2,939 put options.

Institutional Trading of AdaptHealth

A number of hedge funds have recently made changes to their positions in AHCO. Assetmark Inc. purchased a new position in AdaptHealth during the fourth quarter valued at $28,000. Blue Trust Inc. increased its holdings in shares of AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after acquiring an additional 1,115 shares in the last quarter. Quarry LP raised its position in shares of AdaptHealth by 4,596.9% in the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock worth $67,000 after purchasing an additional 5,838 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its stake in AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock worth $121,000 after purchasing an additional 1,690 shares in the last quarter. Finally, CIBC Asset Management Inc purchased a new stake in AdaptHealth during the 3rd quarter valued at about $122,000. 82.67% of the stock is owned by institutional investors.

AdaptHealth Price Performance

Shares of AHCO opened at $11.10 on Thursday. AdaptHealth has a fifty-two week low of $8.35 and a fifty-two week high of $11.90. The firm’s 50-day simple moving average is $9.87 and its two-hundred day simple moving average is $10.21. The stock has a market cap of $1.49 billion, a PE ratio of -6.73, a price-to-earnings-growth ratio of 1.08 and a beta of 1.12. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. UBS Group cut their target price on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Canaccord Genuity Group increased their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday. Robert W. Baird cut their price objective on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. Royal Bank of Canada increased their target price on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, Truist Financial lifted their price target on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $13.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.